.png)
COVID-19 Latest News
Updated: Sep 8, 2021
The novel coronavirus (SARS-CoV-2) pandemic (COVID-19) is a rapidly evolving situation and affecting now over 170 countries. To understand the facts and remove the myths and manage the threat of continued SARS-CoV-2 infection and the risk to public health lets put our strengths together to fight this. For this we provide you with the essential resources and updated information and guidance from WHO, CDC and professional sites like ours. We will continue to post more related scientific papers over the coming weeks as they become available.
APAAACI joins the COVID-19 Recommendations and Gateway to Contextualization
The COVID19 Recommendations and Gateway to Contextualization collects trustworthy recommendations on COVID-19 for clinical, public health and health policy. It allows decision-makers to identify relevant recommendations for their question of interest. APAAACI has joined COVID-19 Evidence Prime as a partner. Read More
Trending News:
Why You Should Not Use Ivermectin to Treat or Prevent COVID-19
COVID vaccines protect against Delta, but their effectiveness wanes
COVID-19 Vaccines for Moderately to Severely Immunocompromised People
Interim Guidelines for COVID-19 Antibody Testing
They Had Mild Covid. Then Their Serious Symptoms Kicked In.
The way in which the new COVID-19 variants transmit hasn’t changed
WATCH NOW
What should you expect after getting a COVID-19 vaccine?
WATCH NOW
How does WHO assess safety of COVID-19 vaccines?
WATCH NOW
Exclusive Webinar Pre-Recorded Viewing:
Topic: PSAAI Press Conference on Allergies and COVID-19 Vaccines: A Heart to Heart Talk
Date: Feb 11, 2021
Shared recording (Accessible with passcode: 8!xNasOL)
Dr. Fauci: The U.S. Will Remain a Member of the World Health Organization
WATCH NOW
COVID Vaccine Conspiracies With Dr. Fauci
WATCH NOW
Dr Katie Allen - Allergist, MP & Important Member of APAAACI - Covid Vaccine Alert
WATCH NOW
WATCH NOW
More News:
COVID-19 Weekly Cases and Deaths per 100,000 Population by Age, Race/Ethnicity, and Sex
Interim Public Health Recommendations for Fully Vaccinated People
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
From paper to digital pathway: WHO launches first ‘SMART Guidelines’
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US
COVID-19 Vaccines and Allergic Reactions
COVAX publishes first interim distribution forecast
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States
Australian COVID-19 vaccine rollout brought forward two weeks to early March
COVID-19 Vaccines: Current Status and Implication for Use in Indonesia
EMA recommends first COVID-19 vaccine for authorisation in the EU
Pfizer-BioNTech COVID-19 Vaccine
This scientist’s decades of mRNA research led to both COVID-19 vaccines
Centers for Disease Control and Prevention - Vaccines (Update)
International Resource Sites:
World Health Organization (WHO): https://www.who.int/
Centers for Disease Control and Prevention (CDC): https://www.cdc.gov/
U.S. Food & Drug Administration (FDA): https://www.fda.gov/home
Gavi The Vaccine Alliance: https://www.gavi.org/